CHANGE IN SIZE OF THE ENVELOPE GLYCOPROTEIN OF A HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) STRAIN

被引:1
作者
VITALE, F
RUSSO, AD
BONURA, F
DIBENEDETTO, MA
MAMMINA, C
ROMANO, N
机构
来源
MICROBIOLOGICA | 1991年 / 14卷 / 01期
关键词
HIV-1; GLYCOPROTEINS;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A strain of HIV 1 (PA 40), isolated from a patient with AIDS, showed a size variation of its external glycoprotein. This glycoprotein had an estimated molecular weight of 105 Kd and differed from that of both HIV 1 IIIb and HIV 2 Rod strains. The protein was derived from a bigger (140 Kd) precursor, detectable only in the infected cells and could incorporate labeled glucose in its prostethic portion. The change in size of the external glycoprotein may be the result of envelope sequence variations since the unglycosylated form of the envelope precursor of PA 40 strain, detected in tunicamycin treated cells, was smaller than that of the HIV 1 IIIb strain. The different size of the external glycoprotein is a further aspect of the variability of the biological characteristic of HIV 1 strains and might be correlated with the emergence of more virulent variants which arose during the progression of the clinical disease.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [21] Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1
    McPherson, Tristan D.
    Sobieszczyk, Magdalena E.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 413 - 420
  • [22] Analysis of the human immunodeficiency virus-1 RNA packageome
    Eckwahl, Matthew J.
    Arnion, Helene
    Kharytonchyk, Siarhei
    Zang, Trinity
    Bieniasz, Paul D.
    Telesnitsky, Alice
    Wolin, Sandra L.
    RNA, 2016, 22 (08) : 1228 - 1238
  • [23] HUMAN IMMUNODEFICIENCY VIRUS-1 DISEASE PROGRESSION IN HEMOPHILIACS
    BECHERER, PR
    SMILEY, ML
    MATTHEWS, TJ
    WEINHOLD, KJ
    MCMILLAN, CW
    WHITE, GC
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (03) : 204 - 209
  • [24] Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon
    Abongwa, Lem Edith
    Nyamache, Anthony Kebira
    Torimiro, Judith Ndongo
    Okemo, Paul
    Charles, Fokunang
    VIROLOGY JOURNAL, 2019, 16 (01)
  • [25] Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
    Duzgunes, Nejat
    Konopka, Krystyna
    PHARMACEUTICS, 2019, 11 (06)
  • [26] Computational Analysis of POL Gene of Human Immunodeficiency Virus Type 1 (HIV-1)
    Behera, Pabitra M.
    Sethi, Bijay K.
    Behera, Kambaska K.
    Pani, Debashrita
    Sahoo, Santilata
    Padhy, Sudarshan
    NOTULAE BOTANICAE HORTI AGROBOTANICI CLUJ-NAPOCA, 2009, 37 (02) : 264 - 269
  • [27] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna A.
    Gendelman H.E.
    Limoges J.
    Rasmussen J.
    Poluektova L.
    Ghorpade A.
    Persidsky Y.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 82 - 90
  • [28] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna, A
    Gendelman, HE
    Limoges, J
    Rasmussen, J
    Poluektova, L
    Ghorpade, A
    Persidsky, Y
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 82 - 90
  • [29] Reconstitution of cleavage of human immunodeficiency virus type-1 (HIV-1) RNAs
    Takahashi, H
    Sawa, H
    Hasegawa, H
    Sata, T
    Hall, WW
    Nagashima, K
    Kurata, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (03) : 1084 - 1091
  • [30] In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs
    Sinck, Lucile
    Richer, Delphine
    Howard, Jane
    Alexander, Marina
    Purcell, Damian F. J.
    Marquet, Roland
    Paillart, Jean-Christophe
    RNA, 2007, 13 (12) : 2141 - 2150